Publicaties
Resultaten gevonden: 29
[ Auteur
Filters: Eerste Letter Van De Achternaam is B [Alle filters opschonen]
Epidemiology of Gamma-hydroxybutyrate (GHB) use and misuse and characteristics of GHB-dependent inpatients. The Neuropathology Of Drug Addictions And Substance Misuse.
.
2016. .
2016. Screening of cognitive disorders in substance abuse patients using the Montreal Cognitive Assessment - Dutch Version (MoCA-D). Journal of the International Neuropsychological Society. 19(Suppl 2)
.
2013. Social anxiety disorder and childhood trauma in the context of anxiety (behavioural inhibition), impulsivity (behavioural activation) and quality of life. South African Journal of Psychiatry. 25:1-7.
.
2019. The Montreal Cognitive Assessment (MoCA) as a cognitive screen in addiction health care: A validation study for clinical practice. Journal of Substance Use. 24(1)
.
2019. Psychometric properties of the Montreal Cognitive Assessment (MoCA) in healthy participants aged 18-70.. Int J Psychiatry Clin Pract. :1-8.
.
2020. Prevalence of cognitive impairment in patients with substance use disorder. The Authors Drug and Alcohol Review .
.
2019. Prevalence of cognitive impairment in patients with substance use disorder. Drug Alcohol Rev. 38(4):435-442.
.
2019. Clinical use of SPECT DaTSCAN in psychiatric population: one-year outcomes of a prospective case series. Psiquiatría Biológica. 21(1)
.
2014. .
2016. Diagnostiek en indicatiestelling. Handboek Forensische Verslavingszorg, In: E. Blaauw & H. Roozen (red.).. :77-104.
.
2012. New evidence of heterogeneity in social anxiety disorder: defining two qualitatively different personality profiles taking into account clinical, environmental and genetic factors. Eur Psychiatry. 30(1):160-5.
.
2015. Common and distinct neural correlates of facial emotion processing in social anxiety disorder and Williams syndrome: A systematic review and voxel-based meta-analysis of functional resonance imaging studies.. Neuropsychologia. 64C:205-217.
.
2014. Baclofen to Prevent Relapse in Gamma-Hydroxybutyrate (GHB)-Dependent Patients: A Multicentre, Open-Label, Non-Randomized, Controlled Trial.. CNS Drugs. 32(5):437-442.
.
2018. A Qualitative Approach in Understanding Illness Perception and Treatment Needs in Patients with Gamma Hydroxybutyrate Use Disorder.. Eur Addict Res. 25(5):248-255.
.
2019. Tapering with Pharmaceutical GHB or Benzodiazepines for Detoxification in GHB-Dependent Patients: A Matched-Subject Observational Study of Treatment-as-Usual in Belgium and The Netherlands.. CNS Drugs. 34(6):651-659.
.
2020. Severe adverse drug reactions in psychiatric inpatients treated with neuroleptics.. Pharmacopsychiatry. 37 Suppl 1:S46-53.
.
2004. Safety and efficacy of combined clozapine-lithium pharmacotherapy.. Int J Neuropsychopharmacol. 7(1):59-63.
.
2004. Hoofdstuk 23 Somatische comorbiditeit bij verslaving. Handboek Verslaving.
.
2019. Screening for substance use disorders in first-episode psychosis: implications for readmission.. Schizophr Res. 146(1-3):125-31.
.
2013. Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings.. PLoS One. 8(2):e55821.
.
2013. Apoptotic markers in cultured fibroblasts correlate with brain metabolites and regional brain volume in antipsychotic-naive first-episode schizophrenia and healthy controls.. Transl Psychiatry. 5:e626.
.
2015. Modulation of brain structure by catechol-O-methyltransferase Val(158) Met polymorphism in chronic cannabis users.. Addict Biol. 19(4):722-32.
.
2014. The role of the habenula in the transition from reward to misery in substance use and mood disorders.. Neurosci Biobehav Rev.
.
2017. Antipsychotic treatment in a patient with schizophrenia undergoing hemodialysis.. J Clin Psychopharmacol. 30(1):92-4.
.
2010.